Alteration of Rb binding to HPV 18 E7 modified by transglutaminase 2 with different type of polyamines

Frontiers in Bioscience

Volumn 11, Issue 2 P.1199-1590, 2006, Pages 1540-1548

  Jeon, Ju Hong ^a   Cho, Sung Yup ^a   Kim, Chai Wan ^a   Shin, Dong Myung ^a   Jang, Gi Yong ^a   Lee, Hye Jin ^a   Kang, Heun Soo ^a   Park, Sang Chul ^a   Kim, In Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Human Papillomavirus E7; Polyamination; Spermine; Spermidine; Transglutaminase 2

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES;

EID: 32844469943     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1902     Document Type: Article

References (35)

1. Clifford G.M., J.S. Smith, M. Plummer, N. Munoz & S. Franceschi: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88, 63-73 (2003)
2. Munger K. & P.M. Howley: Human papillomavirus immortalization and transformation functions. Virus Res 89, 213-228 (2002)
3. Woodman C.B., S. Collins, H. Winter, A. Bailey, J. Ellis, P. Prior, M. Yates, T.P. Rollason & L.S. Young: Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357, 1831-1836 (2001)
4. Munoz N., F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer & International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518-527 (2003)
5. Walboomers J.M., M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer & N. Munoz: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19 (1999)
6. Sherman M.E., A.T. Lorincz, D.R. Scott, S. Wacholder, P.E. Castle, A.G. Glass, I. Mielzynska-Lohnas, B.B. Rush & M. Schiffman: Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95, 46-52 (2003)
7. Munger K., J.R. Basile, S. Duensing, A. Eichten, S.L. Gonzalez, M. Grace & V.L. Zacny: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898 (2001)
8. Chan P.K., C.W. Lam, T.H. Cheung, W.W. Li, K.W. Lo, M.Y. Chan, J.L. Cheung & A.F. Cheng: Association of human papillomavirus type 58 variant with the risk of cervical cancer. J. Natl. Cancer. Inst 94, 1249-1253 (2002)
9. Jiang M. & J. Milner: Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21, 6041-6048 (2002)
10. Riley R.R., S. Duensing, T. Brake, K. Munger, P.F. Lambert & J.M. Arbeit: Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63, 4862-4871 (2003)
11. Lorand L. &, R.M. Graham: Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4, 140-156 (2003)
12. Wallace H.M., A. V. Fraser & A. Hughes: A perspective of polyamine metabolism. Biochem J 376, 1-14 (2003)
13. Igarashi K. & K. Kashiwagi: Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271, 559-564 (2000)
14. Jeon J.H. & I.G. Kim: Role of protein modification mediated by transglutaminase 2 in human viral diseases. Front Biosci 11, 221-231 (2006)
15. Jeon J.H., K.H. Choi, S.Y. Cho, C.W. Kim, D.M. Shin, J.C. Kwon, K.Y. Song, S.C. Park & I.G. Kim, Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine. EMBO J 22, 5273-5282 (2003)
16. Jeon J.H., C.W. Kim, D.M. Shin, K. Kim, S.Y. Cho, J.C. Kwon, K.H. Choi, H.S. Kang & I.G. Kim: Differential incorporation of biotinylated polyamines by transglutaminase 2. FEBS Lett 534, 180-184 (2003)
17. Shin D.M., J.H. Jeon, C.W. Kim, S.Y. Cho, J.C. Kwon, H.J. Lee, K.H. Choi, S.C. Park & I.G. Kim: Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 279, 15032-15039 (2004)
18. Jeon J.H., H.J. Lee, G.Y. Jang, C.W. Kim, D.M. Shin D.M., S.Y. Cho, E.J. Yeo, S.C. Park & I.G. Kim: Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine. Exp Mol Med 36, 576-581 (2004)
19. Fesus L. & Z. Szondy: Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579, 3297-3302 (2005)
20. De Laurenzi V. & G. Melino: Gene disruption of tissue transglutaminase. Mol Cell Biol 21, 148-155 (2001)
21. Boehm J.E., U. Singh, C. Combs, M.A. Antonyak & R.A. Cerione: Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 277, 20127-20130 (2002)
22. Antonyak M.A., A.M. Miller, J.M. Jansen, J.E. Boehm, C.E. Balkman, J.J. Wakshlag, R.L. Page & R.A. Cerione. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 279, 41461-41467 (2004)
23. Sato N., Y. Ohtake, H. Kato, S. Abe, H. Kohno & Y. Ohkubo. Effects of polyamines on histone polymerization. J Protein Chem 22, 303-307 (2003)
24. Pendeville H., N. Carpino, J.C. Marine, Y. Takahashi, M. Muller, J.A. Martial & J.L. Cleveland: The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 21, 6549-6558 (2001)
25. Pietila M., L. Alhonen, M. Halmekyto, P. Kanter, J. Janne & C.W. Porter: Activation of polyamine catabolism profoundly alters tissue polyamine pools and affects hair growth and female fertility in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase. J Biol Chem 272, 18746-18751 (1997)
26. Soler A.P., G. Gilliard, L.C. Megosh & T.G. O'Brien: Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J Invest Dermatol 106, 1108-1113 (1996)
27. Robinson N.E. & A.B. Robinson: Deamidation of human proteins. Proc Natl Acad Sci USA 98, 12409-12413 (2001)
28. Candi E., R. Schmidt & G. Melino: The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6, 328-340 (2005)
29. Amendola A., M.L. Gougeon, F. Poccia, A. Bondurand, L. Fesus & M. Piacentini: Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci USA 93, 11057-11062 (1996)
30. Lu W., A. Strohecker & J.H. Ou Jh: Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase. J Biol Chem 276, 47993-47999 (2001)
31. Mariniello L., C. Esposito, V. Gentile & R. Porta: Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein gp120 in vitro. Int J Pept Protein Res 42, 204-206 (1993)
32. Mariniello L., C. Esposito, P. Di Pierro, A. Cozzolino, P. Pucci & R. Porta: Human-immunodeficiency-virus transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro. Eur J Biochem 215, 99-104 (1993)
33. Beninati S. & A.B. Mukherjee: A novel transglutaminase-catalyzed posttranslational modification of HIV-1 aspartyl protease. Biochem Biophys Res Commun 187, 1211-1218 (1992)
34. Nardacci R., F. Ciccosanti, L. Falasca, O. Lo Iacono, A. Amendola, G. Antonucci & M. Piacentini: Tissue transglutaminase in HCV infection. Cell Death Differ 10, S79-80 (2003)
35. Bevec D., H. Jaksche, M. Oft, T. Wohl, M. Himmelspach, A. Pacher, M. Schebesta, K. Koettnitz, M. Dobrovnik, R. Csonga, F. Lottspeich & J. Hauber: Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271, 1858-1860 (1996)